Estate Counselors’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Estate Counselors’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$1K	–	75
2016 Q3	$1K	Hold	10,000	–	–	﹤0.01%	54
2016 Q2	$4K	Hold	10,000	–	–	﹤0.01%	54
2016 Q1	$4K	Hold	10,000	–	–	﹤0.01%	54
2015 Q4	$4K	Buy	+10,000	New	+$4.74K	﹤0.01%	65
2015 Q2	–	Sell	-10,000	Closed	-$8K	–	54
2015 Q1	$8K	Hold	10,000	–	–	﹤0.01%	53
2014 Q4	$8K	Hold	10,000	–	–	﹤0.01%	59
2014 Q3	$10K	Buy	+10,000	New	+$9.69K	﹤0.01%	51

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Estate Counselors's PVCT Position: Q4 2016 in Review

Estate Counselors sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 10,000 shares — an estimated $1K sold.

Estate Counselors first reported a position in PVCT in Q3 2014 and held it in 7 quarters. The position peaked at $10K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Estate Counselors reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Estate Counselors sold 10,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $1K.
Estate Counselors first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q3 2014 and held it in 7 quarters.
Estate Counselors's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $10K in Q3 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Estate Counselors's 13F filing for Q4 2016, filed 24 Jan 2017.